Tag: opportunities
Pfizer execs see blockbuster opportunities throughout vaccine pipeline, beyond pneumonia and...
Pfizer has made billions on its best-selling vaccine, Prevnar 13, but it's meanwhile advancing several phase 3 candidates to follow that product and bolster its presence in...